FEATURED
-
Global generic drug markets will grow to US$221 billion by 2016
Driven by the need to control costs, the use of generic drugs has grown considerably in recent years, even in markets where traditionally they have not been favored.
FEATURED | 23 May 2012
-
Astellas site implements Werum’s PAS-X
The MES will introduce efficient and state-of-the-art paperless electronic batch recording functionality supporting compliant, efficient and lean production processes.
FEATURED | 22 May 2012
-
Burgopak launch Chrysalis Carton in partnership with Medica Packaging
The solution connects the outer carton and patient information leaflet (PIL) conveniently together. The patient pulls a perforated flap on the carton to expose the patient leaflet, which they can unfold to display the product information.
FEATURED | 21 May 2012
-
US Supreme Court clears way for generic patent challenges
After the ruling, generic manufacturers will now be able to challenge the content of patent descriptions and, if successful, ultimately force approval of the ANDA. Writing for the Court in a unanimous decision, Justice Elena Kagan chastised the FDA for using ambiguous or opaque guidelines and forms that lend to the confusion surrounding patent decisions.
FEATURED | 18 May 2012
-
Anti-trust authorities approve Bosch’s acquisition of Eisai Machinery
Bosch finalized the acquisition of the machinery business companies of Eisai, one of the leading Japanese pharmaceutical companies based in Tokyo. The transaction has been approved by the antitrust authorities without further restrictions.
FEATURED | 14 May 2012
-
Watson in talks to buy Actavis
Watson Pharmaceuticals is currently in talks to buy private Swiss generic drug maker Actavis.
FEATURED | 11 May 2012
-
Kuehne + Nagel launches innovative airfreight solution for pharmaceutical products
KN PharmaChain offers – among other features – door-to-door temperature control, a 24 hour alert system, optional wireless temperature measuring and best practice (GxP) standards for facilities, working processes and training programmes.
FEATURED | 08 May 2012
-
Phosphagenics signs agreement with Nippon Zoki
The companies have struck a material transfer agreement which enables Nippon Zoki to test and assess Phosphagenics’ patented TPM/diclofenac topical non-steroidal pain formulation for its suitability as a prescription item in the USA and Japanese markets.
FEATURED | 03 May 2012
-
Aslan Pharmaceuticals selects PharmaNet/i3 as partner for oncology development
Aslan Pharmaceuticals has selected PharmaNet/i3 as a partner supporting the development of their oncology portfolio in Asia.
FEATURED | 02 May 2012
-
More investment needed in anti-obesity drugs
Pharmaceutical companies should increase their investment in anti-obesity drug therapies to support the growing number of clinically obese individuals worldwide, a report by GlobalData has found.
FEATURED | 01 May 2012
